200 related articles for article (PubMed ID: 28550122)
21. The structure of human α-2,6-sialyltransferase reveals the binding mode of complex glycans.
Kuhn B; Benz J; Greif M; Engel AM; Sobek H; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1826-38. PubMed ID: 23999306
[TBL] [Abstract][Full Text] [Related]
22. The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.
Britain CM; Dorsett KA; Bellis SL
J Biol Chem; 2017 Mar; 292(11):4663-4673. PubMed ID: 28154177
[TBL] [Abstract][Full Text] [Related]
23. Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts.
Dalziel M; Lemaire S; Ewing J; Kobayashi L; Lau JT
Glycobiology; 1999 Oct; 9(10):1003-8. PubMed ID: 10521536
[TBL] [Abstract][Full Text] [Related]
24. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Holdbrooks AT; Britain CM; Bellis SL
J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
[TBL] [Abstract][Full Text] [Related]
25. Beta-galactoside alpha2,6-sialyltransferase I cleavage by BACE1 enhances the sialylation of soluble glycoproteins. A novel regulatory mechanism for alpha2,6-sialylation.
Sugimoto I; Futakawa S; Oka R; Ogawa K; Marth JD; Miyoshi E; Taniguchi N; Hashimoto Y; Kitazume S
J Biol Chem; 2007 Nov; 282(48):34896-903. PubMed ID: 17897958
[TBL] [Abstract][Full Text] [Related]
26. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
Chen X; Wang L; Yu X; Wang S; Zhang J
Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
[TBL] [Abstract][Full Text] [Related]
27. Alpha-2,6-sialylation regulation in CD34+ progenitor cells in the human bone marrow and granulocyte colony-stimulating factor mobilization.
Hui N; Le Marer N
J Hematother Stem Cell Res; 2001 Oct; 10(5):661-8. PubMed ID: 11672512
[TBL] [Abstract][Full Text] [Related]
28. Development of sandwich enzyme-linked immunosorbent assay systems for plasma beta-galactoside alpha2,6-sialyltransferase, a possible hepatic disease biomarker.
Futakawa S; Kitazume S; Oka R; Ogawa K; Hagiwara Y; Kinoshita A; Miyashita K; Hashimoto Y
Anal Chim Acta; 2009 Jan; 631(1):116-20. PubMed ID: 19046688
[TBL] [Abstract][Full Text] [Related]
29. B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism.
Irons EE; Lee-Sundlov MM; Zhu Y; Neelamegham S; Hoffmeister KM; Lau JT
Elife; 2019 Aug; 8():. PubMed ID: 31408003
[TBL] [Abstract][Full Text] [Related]
30. Ras oncogene induces beta-galactoside alpha2,6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter.
Dalziel M; Dall'Olio F; Mungul A; Piller V; Piller F
Eur J Biochem; 2004 Sep; 271(18):3623-34. PubMed ID: 15355339
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes.
Takashima S; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Nov; 277(48):45719-28. PubMed ID: 12235148
[TBL] [Abstract][Full Text] [Related]
32. ST6Gal-I-mediated sialylation of the epidermal growth factor receptor modulates cell mechanics and enhances invasion.
Rao TC; Beggs RR; Ankenbauer KE; Hwang J; Ma VP; Salaita K; Bellis SL; Mattheyses AL
J Biol Chem; 2022 Apr; 298(4):101726. PubMed ID: 35157848
[TBL] [Abstract][Full Text] [Related]
33. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation.
Dalziel M; Huang RY; Dall'Olio F; Morris JR; Taylor-Papadimitriou J; Lau JT
Glycobiology; 2001 May; 11(5):407-12. PubMed ID: 11425801
[TBL] [Abstract][Full Text] [Related]
34. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
Shaikh FM; Seales EC; Clem WC; Hennessy KM; Zhuo Y; Bellis SL
Exp Cell Res; 2008 Oct; 314(16):2941-50. PubMed ID: 18703050
[TBL] [Abstract][Full Text] [Related]
35. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
Liu Z; Swindall AF; Kesterson RA; Schoeb TR; Bullard DC; Bellis SL
J Biol Chem; 2011 Nov; 286(45):39654-62. PubMed ID: 21930713
[TBL] [Abstract][Full Text] [Related]
36. The glycosyltransferase ST6Gal-I is enriched in cancer stem-like cells in colorectal carcinoma and contributes to their chemo-resistance.
Cui H; Yang S; Jiang Y; Li C; Zhao Y; Shi Y; Hao Y; Qian F; Tang B; Yu P
Clin Transl Oncol; 2018 Sep; 20(9):1175-1184. PubMed ID: 29423671
[TBL] [Abstract][Full Text] [Related]
37. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
38. [ST6Gal I siRNA and antisense oligonucleotide-mediated gene silencing lowers the invasiveness potential of colonic carcinoma cells].
Yuan TH; Li MY; Li WY; Li H; Jiang ZH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Feb; 27(2):136-40. PubMed ID: 17355919
[TBL] [Abstract][Full Text] [Related]
39. Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
Smithson M; Irwin R; Williams G; Alexander KL; Smythies LE; Nearing M; McLeod MC; Al Diffalha S; Bellis SL; Hardiman KM
J Biol Chem; 2022 Mar; 298(3):101594. PubMed ID: 35041825
[TBL] [Abstract][Full Text] [Related]
40. The generation of influenza-specific humoral responses is impaired in ST6Gal I-deficient mice.
Zeng J; Joo HM; Rajini B; Wrammert JP; Sangster MY; Onami TM
J Immunol; 2009 Apr; 182(8):4721-7. PubMed ID: 19342648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
